Saul Yanovich - Concepedia

Author

Saul Yanovich

Virginia Commonwealth University Medical Center

Also Known As

Bensinger, William, John Wagner, S Yanovich, S. Yanovich, SAUL YANOVICH, Saul Yanovich

Publications

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University Medical Center Memorial Sloan Kettering Cancer Center University of Maryland, Baltimore University of Minnesota Dana-Farber Cancer Institute

About

Saul Yanovich is an author at Virginia Commonwealth University Medical Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	1.8K
2	Biochemistry	10	11	273
3	Health Sciences	8	8	208
4	Natural Sciences	5	5	111
5	Engineering	2	2	45

Saul Yanovich

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever Thomas J. Walsh, Peter G. Pappas, Drew J. Winston, New England Journal of Medicine	2002	985
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers Ricardo Spielberger, Patrick J. Stiff, William Bensinger, New England Journal of Medicine	2004	890
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorAntigen-specific Antitumor Effects	2015	832
Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study Hillard M. Lazarus, Jeffrey L. Blumer, Saul Yanovich, The Journal of Clinical Pharmacology	2002	167
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. Thomas J. Smith, Bruce E. Hillner, Norbert Schmitz, Journal of Clinical Oncology	1997	165
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma Aaron P. Rapoport, Nicole A. Aqui, Edward A. Stadtmauer, Blood	2010	163
A Scheme for Defining Cause of Death and Its Application in the T Cell Depletion Trial Edward A. Copelan, James T. Casper, Shelly L. Carter, Biology of Blood and Marrow Transplantation Cell TherapyTransplantation CentersApoptosisImmunologyT-regulatory Cell	2007	153
Higher Risk of Cytomegalovirus and Aspergillus Infections in Recipients of T Cell–Depleted Unrelated Bone Marrow: Analysis of Infectious Complications in Patients Treated with T Cell Depletion Versus Immunosuppressive Therapy to Prevent Graft-versus-Host Disease Jo‐Anne H. van Burik, Shelly L. Carter, Alison G. Freifeld, Biology of Blood and Marrow Transplantation Aspergillus InfectionsImmunodeficienciesTransplantation MedicineImmunologyImmunotherapy	2007	151
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. Jeffrey Crawford, Mark Allen O’Rourke, Joan H. Schiller, Journal of Clinical Oncology	1996	124
Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells Aaron P. Rapoport, Nicole A. Aqui, Edward A. Stadtmauer, Clinical Cancer Research	2014	123

Page 1